Voyager Therapeutics (VYGR) Operating Income Growth (1y) (2015 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Operating Income Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 48.27% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 54.38% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 363.47% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -88.50% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 121.39% |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | 27.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.94% |
| Mar 31, 2026 | 12.75% |
| Dec 31, 2025 | 21.85% |
| Sep 30, 2025 | -122.02% |
| Jun 30, 2025 | -143.76% |
| Mar 31, 2025 | -114.38% |
| Dec 31, 2024 | -170.84% |
| Sep 30, 2024 | 53.30% |
| Jun 30, 2024 | 40.91% |
| Mar 31, 2024 | -113.17% |
| Dec 31, 2023 | 320.10% |
| Sep 30, 2023 | -304.31% |
| Jun 30, 2023 | -31.29% |
| Mar 31, 2023 | 675.57% |
| Dec 31, 2022 | -530.78% |
| Sep 30, 2022 | 157.43% |
| Jun 30, 2022 | 32.25% |
| Mar 31, 2022 | 16.57% |
| Dec 31, 2021 | 124.03% |
| Sep 30, 2021 | -129.75% |